WSR 22-02-025
PERMANENT RULES
HEALTH CARE AUTHORITY
[Filed December 28, 2021, 10:21 a.m., effective February 1, 2022]
Effective Date of Rule: February 1, 2022.
Purpose: The agency amended this rule to add the HPV vaccine as a covered service under the family planning only program.
Citation of Rules Affected by this Order: Amending WAC 182-532-530.
Statutory Authority for Adoption: RCW 41.05.021, 41.05.160.
Adopted under notice filed as WSR 21-22-062 on October 28, 2021.
Number of Sections Adopted in Order to Comply with Federal Statute: New 0, Amended 0, Repealed 0; Federal Rules or Standards: New 0, Amended 0, Repealed 0; or Recently Enacted State Statutes: New 0, Amended 0, Repealed 0.
Number of Sections Adopted at the Request of a Nongovernmental Entity: New 0, Amended 0, Repealed 0.
Number of Sections Adopted on the Agency's own Initiative: New 0, Amended 0, Repealed 0.
Number of Sections Adopted in Order to Clarify, Streamline, or Reform Agency Procedures: New 0, Amended 1, Repealed 0.
Number of Sections Adopted using Negotiated Rule Making: New 0, Amended 0, Repealed 0; Pilot Rule Making: New 0, Amended 0, Repealed 0; or Other Alternative Rule Making: New 0, Amended 1, Repealed 0.
Date Adopted: December 28, 2021.
Wendy Barcus
Rules Coordinator
OTS-3334.1
AMENDATORY SECTION(Amending WSR 19-18-024, filed 8/28/19, effective 10/1/19)
WAC 182-532-530Family planning only programsCovered services.
The medicaid agency covers all of the following services:
(1) One comprehensive preventive family planning visit once every twelve months, based on nationally recognized clinical guidelines. This visit must have a primary focus and diagnosis of family planning and include counseling, education, risk reduction, and initiation or management of contraceptive methods;
(2) Assessment and management of family planning or contraceptive problems, when medically necessary;
(3) Contraception, including:
(a) Food and Drug Administration (FDA)-approved contraceptive methods, as described under WAC 182-530-2000;
(b) Education and supplies for Federal Drug Administration (FDA)-approved contraceptive, natural family planning, and abstinence; and
(c) Sterilization procedures, as described under WAC 182-531-1550.
(4) The following services, when appropriate, during a visit focused on family planning:
(a) Pregnancy testing;
(b) Cervical cancer screening, according to nationally recognized clinical guidelines;
(c) Gonorrhea and chlamydia screening and treatment for clients age thirteen through twenty-five, according to nationally recognized clinical guidelines;
(d) Syphilis screening and treatment for clients who have an increased risk for syphilis, according to nationally recognized guidelines; and
(e) Sexually transmitted infection (STI) screening, testing, and treatment, when medically indicated by symptoms or report of exposure, and medically necessary for the client's safe and effective use of their chosen contraceptive method.
(5) Human papillomavirus (HPV) vaccines.